OverviewSuggest Edit

Hoth Therapeutics is a development stage biopharmaceutical company focused on targeted therapeutics for patients suffering from indications such as atopic dermatitis. The Company also develops the BioLexa Platform, a product candidate intended to prevent the symptom-triggering flare-ups before they occur.

TypePublic
HQNew York, US
Websitehoththerapeutics.com

Latest Updates

Employees (est.) (Mar 2019)2
Share Price (Nov 2019)$4.3 (-3%)

Hoth Therapeutics Office Locations

Hoth Therapeutics has an office in New York
New York, US (HQ)
1 Rockefeller Plaza, 10th Floor
Show all (1)

Hoth Therapeutics Financials and Metrics

Hoth Therapeutics Revenue

USD

Net income (Q2, 2019)

(1.3m)

EBIT (Q2, 2019)

(1.3m)

Market capitalization (15-Nov-2019)

43.9m

Closing stock price (15-Nov-2019)

4.3

Cash (30-Jun-2019)

4.1m
Hoth Therapeutics's current market capitalization is $43.9 m.
Annual
USDFY, 2017FY, 2018

General and administrative expense

1.2m

R&D expense

586.8k785.3k

Operating expense total

1.9m785.3k

EBIT

(1.9m)(2.5m)
Quarterly
USDQ1, 2019Q2, 2019

R&D expense

134.8k388.9k

Operating expense total

134.8k388.9k

EBIT

(829.4k)(1.3m)

Net Income

(829.4k)(1.3m)
Annual
USDFY, 2017FY, 2018

Cash

1.2m282.6k

Prepaid Expenses

12.4k

Current Assets

1.2m501.6k

PP&E

3.5k2.3k
Quarterly
USDQ2, 2018Q3, 2018Q1, 2019Q2, 2019

Cash

1.5m737.7k5.2m4.1m

Prepaid Expenses

27.2k19.8k88.3k101.3k

Current Assets

1.5m757.5k5.3m4.2m

PP&E

2.9k2.6k2.0k1.7k
Annual
USDFY, 2017FY, 2018

Net Income

(2.0m)(2.5m)

Depreciation and Amortization

188.01.2k

Accounts Payable

47.9k94.4k

Cash From Operating Activities

(465.2k)(2.1m)
Quarterly
USDQ3, 2017Q3, 2018Q1, 2019Q2, 2019

Net Income

(1.7m)(1.9m)(829.4k)(2.1m)

Depreciation and Amortization

916.0302.0608.0

Accounts Payable

1.5k(22.2k)(71.7k)65.0k

Cash From Operating Activities

(240.3k)(1.6m)(764.0k)(1.8m)
USDY, 2019

Financial Leverage

1.1 x
Show all financial metrics

Hoth Therapeutics Online and Social Media Presence

Embed Graph

Hoth Therapeutics News and Updates

Hoth Therapeutics Inc. Announces Closing of Initial Public Offering

NEW YORK, Feb. 20, 2019 /PRNewswire/ -- Hoth Therapeutics Inc. ("Hoth" or the "Company"), a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema, today announced the...

Hoth Therapeutics Blogs

HOTH THERAPEUTICS, INC. TO PRESENT AT THE THINKEQUITY CONFERENCE

NEW YORK, April 30, 2019 /PRNewswire/ — Hoth Therapeutics, Inc. (Nasdaq: HOTH) a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chronic wound disorders, today annou…

Hoth Therapeutics Frequently Asked Questions

  • How many employees does Hoth Therapeutics have?

    Hoth Therapeutics has 2 employees.

  • Who are Hoth Therapeutics competitors?

    Competitors of Hoth Therapeutics include Synthorx, Innovation Pharmaceuticals and Veloxis Pharmaceuticals.

  • Where is Hoth Therapeutics headquarters?

    Hoth Therapeutics headquarters is located at 1 Rockefeller Plaza, 10th Floor, New York.

  • Where are Hoth Therapeutics offices?

    Hoth Therapeutics has an office in New York.

  • How many offices does Hoth Therapeutics have?

    Hoth Therapeutics has 1 office.